Chapter 1. Research Scope

1.1. Research Objectives

1.2. Market Definition

1.3. Analysis Period

1.4. Market Size Breakdown by Segments

1.4.1. Market size breakdown, by product type

1.4.2. Market size breakdown, by analyte type

1.4.3. Market size breakdown, by application

1.4.4. Market size breakdown, by end user

1.4.5. Market size breakdown, by region

1.4.6. Market size breakdown, by country

1.5. Market Data Reporting Unit

1.5.1. Value

1.6. Key Stakeholders

Chapter 2. Research Methodology

2.1. Secondary Research

2.1.1. Paid

2.1.2. Unpaid

2.1.3. P&S Intelligence database

2.2. Primary Research

2.3. Market Size Estimation

2.4. Data Triangulation

2.5. Currency Conversion Rates

2.6. Assumptions for the Study

2.7. Notes and Caveats

Chapter 3. Executive Summary

Chapter 4. Voice of Industry Experts/KOLs

Chapter 5. Market Indicators

Chapter 6. Industry Outlook

6.1. Market Dynamics

6.1.1. Trends

6.1.2. Drivers

6.1.3. Restraints/challenges

6.1.4. Impact analysis of drivers/restraints

6.2. Impact of COVID-19

6.3. Porter’s Five Forces Analysis

6.3.1. Bargaining power of buyers

6.3.2. Bargaining power of suppliers

6.3.3. Threat of new entrants

6.3.4. Intensity of rivalry

6.3.5. Threat of substitutes

Chapter 7. Global Market

7.1. Overview

7.2. Market Revenue, by Product Type (2017–2030)

7.2.1. Instrument-specific controls market revenue, by type (2017–2030)

7.3. Market Revenue, by Analyte Type (2017–2030)

7.4. Market Revenue, by Application (2017–2030)

7.5. Market Revenue, by End User (2017–2030)

7.6. Market Revenue, by Region (2017–2030)

Chapter 8. North America Market

8.1. Overview

8.2. Market Revenue, by Product Type (2017–2030)

8.2.1. Instrument-specific controls market revenue, by type (2017–2030)

8.3. Market Revenue, by Analyte Type (2017–2030)

8.4. Market Revenue, by Application (2017–2030)

8.5. Market Revenue, by End User (2017–2030)

8.6. Market Revenue, by Country (2017–2030)

Chapter 9. Europe Market

9.1. Overview

9.2. Market Revenue, by Product Type (2017–2030)

9.2.1. Instrument-specific controls market revenue, by type (2017–2030)

9.3. Market Revenue, by Analyte Type (2017–2030)

9.4. Market Revenue, by Application (2017–2030)

9.5. Market Revenue, by End User (2017–2030)

9.6. Market Revenue, by Country (2017–2030)

Chapter 10. APAC Market

10.1. Overview

10.2. Market Revenue, by Product Type (2017–2030)

10.2.1. Instrument-specific controls market revenue, by type (2017–2030)

10.3. Market Revenue, by Analyte Type (2017–2030)

10.4. Market Revenue, by Application (2017–2030)

10.5. Market Revenue, by End User (2017–2030)

10.6. Market Revenue, by Country (2017–2030)

Chapter 11. LATAM Market

11.1. Overview

11.2. Market Revenue, by Product Type (2017–2030)

11.2.1. Instrument-specific controls market revenue, by type (2017–2030)

11.3. Market Revenue, by Analyte Type (2017–2030)

11.4. Market Revenue, by Application (2017–2030)

11.5. Market Revenue, by End User (2017–2030)

11.6. Market Revenue, by Country (2017–2030)

Chapter 12. MEA Market

12.1. Overview

12.2. Market Revenue, by Product Type (2017–2030)

12.2.1. Instrument-specific controls market revenue, by type (2017–2030)

12.3. Market Revenue, by Analyte Type (2017–2030)

12.4. Market Revenue, by Application (2017–2030)

12.5. Market Revenue, by End User (2017–2030)

12.6. Market Revenue, by Country (2017–2030)

Chapter 13. U.S. Market

13.1. Overview

13.2. Market Revenue, by Product Type (2017–2030)

13.2.1. Instrument-specific controls market revenue, by type (2017–2030)

13.3. Market Revenue, by Analyte Type (2017–2030)

13.4. Market Revenue, by Application (2017–2030)

13.5. Market Revenue, by End User (2017–2030)

Chapter 14. Canada Market

14.1. Overview

14.2. Market Revenue, by Product Type (2017–2030)

14.2.1. Instrument-specific controls market revenue, by type (2017–2030)

14.3. Market Revenue, by Analyte Type (2017–2030)

14.4. Market Revenue, by Application (2017–2030)

14.5. Market Revenue, by End User (2017–2030)

Chapter 15. Germany Market

15.1. Overview

15.2. Market Revenue, by Product Type (2017–2030)

15.2.1. Instrument-specific controls market revenue, by type (2017–2030)

15.3. Market Revenue, by Analyte Type (2017–2030)

15.4. Market Revenue, by Application (2017–2030)

15.5. Market Revenue, by End User (2017–2030)

Chapter 16. France Market

16.1. Overview

16.2. Market Revenue, by Product Type (2017–2030)

16.2.1. Instrument-specific controls market revenue, by type (2017–2030)

16.3. Market Revenue, by Analyte Type (2017–2030)

16.4. Market Revenue, by Application (2017–2030)

16.5. Market Revenue, by End User (2017–2030)

Chapter 17. U.K. Market

17.1. Overview

17.2. Market Revenue, by Product Type (2017–2030)

17.2.1. Instrument-specific controls market revenue, by type (2017–2030)

17.3. Market Revenue, by Analyte Type (2017–2030)

17.4. Market Revenue, by Application (2017–2030)

17.5. Market Revenue, by End User (2017–2030)

Chapter 18. Italy Market

18.1. Overview

18.2. Market Revenue, by Product Type (2017–2030)

18.2.1. Instrument-specific controls market revenue, by type (2017–2030)

18.3. Market Revenue, by Analyte Type (2017–2030)

18.4. Market Revenue, by Application (2017–2030)

18.5. Market Revenue, by End User (2017–2030)

Chapter 19. Spain Market

19.1. Overview

19.2. Market Revenue, by Product Type (2017–2030)

19.2.1. Instrument-specific controls market revenue, by type (2017–2030)

19.3. Market Revenue, by Analyte Type (2017–2030)

19.4. Market Revenue, by Application (2017–2030)

19.5. Market Revenue, by End User (2017–2030)

Chapter 20. Japan Market

20.1. Overview

20.2. Market Revenue, by Product Type (2017–2030)

20.2.1. Instrument-specific controls market revenue, by type (2017–2030)

20.3. Market Revenue, by Analyte Type (2017–2030)

20.4. Market Revenue, by Application (2017–2030)

20.5. Market Revenue, by End User (2017–2030)

Chapter 21. China Market

21.1. Overview

21.2. Market Revenue, by Product Type (2017–2030)

21.2.1. Instrument-specific controls market revenue, by type (2017–2030)

21.3. Market Revenue, by Analyte Type (2017–2030)

21.4. Market Revenue, by Application (2017–2030)

21.5. Market Revenue, by End User (2017–2030)

Chapter 22. India Market

22.1. Overview

22.2. Market Revenue, by Product Type (2017–2030)

22.2.1. Instrument-specific controls market revenue, by type (2017–2030)

22.3. Market Revenue, by Analyte Type (2017–2030)

22.4. Market Revenue, by Application (2017–2030)

22.5. Market Revenue, by End User (2017–2030)

Chapter 23. Australia Market

23.1. Overview

23.2. Market Revenue, by Product Type (2017–2030)

23.2.1. Instrument-specific controls market revenue, by type (2017–2030)

23.3. Market Revenue, by Analyte Type (2017–2030)

23.4. Market Revenue, by Application (2017–2030)

23.5. Market Revenue, by End User (2017–2030)

Chapter 24. South Korea Market

24.1. Overview

24.2. Market Revenue, by Product Type (2017–2030)

24.2.1. Instrument-specific controls market revenue, by type (2017–2030)

24.3. Market Revenue, by Analyte Type (2017–2030)

24.4. Market Revenue, by Application (2017–2030)

24.5. Market Revenue, by End User (2017–2030)

Chapter 25. Brazil Market

25.1. Overview

25.2. Market Revenue, by Product Type (2017–2030)

25.2.1. Instrument-specific controls market revenue, by type (2017–2030)

25.3. Market Revenue, by Analyte Type (2017–2030)

25.4. Market Revenue, by Application (2017–2030)

25.5. Market Revenue, by End User (2017–2030)

Chapter 26. Mexico Market

26.1. Overview

26.2. Market Revenue, by Product Type (2017–2030)

26.2.1. Instrument-specific controls market revenue, by type (2017–2030)

26.3. Market Revenue, by Analyte Type (2017–2030)

26.4. Market Revenue, by Application (2017–2030)

26.5. Market Revenue, by End User (2017–2030)

Chapter 27. Saudi Arabia Market

27.1. Overview

27.2. Market Revenue, by Product Type (2017–2030)

27.2.1. Instrument-specific controls market revenue, by type (2017–2030)

27.3. Market Revenue, by Analyte Type (2017–2030)

27.4. Market Revenue, by Application (2017–2030)

27.5. Market Revenue, by End User (2017–2030)

Chapter 28. South Africa Market

28.1. Overview

28.2. Market Revenue, by Product Type (2017–2030)

28.2.1. Instrument-specific controls market revenue, by type (2017–2030)

28.3. Market Revenue, by Analyte Type (2017–2030)

28.4. Market Revenue, by Application (2017–2030)

28.5. Market Revenue, by End User (2017–2030)

Chapter 29. U.A.E. Market

29.1. Overview

29.2. Market Revenue, by Product Type (2017–2030)

29.2.1. Instrument-specific controls market revenue, by type (2017–2030)

29.3. Market Revenue, by Analyte Type (2017–2030)

29.4. Market Revenue, by Application (2017–2030)

29.5. Market Revenue, by End User (2017–2030)

Chapter 30. Competitive Landscape

30.1. List of Market Players and their Offerings

30.2. Competitive Benchmarking of Key Players

30.3. Product Benchmarking of Key Players

30.4. Recent Strategic Developments

Chapter 31. Company Profiles

31.1. LGC Limited

31.1.1. Business overview

31.1.2. Product and service offerings

31.2. Thermo Fisher Scientific Inc.

31.2.1. Business overview

31.2.2. Product and service offerings

31.2.3. Key financial summary

31.3. Bio-Rad Laboratories Inc.

31.3.1. Business overview

31.3.2. Product and service offerings

31.3.3. Key financial summary

31.4. F. Hoffmann-La Roche Ltd.

31.4.1. Business overview

31.4.2. Product and service offerings

31.4.3. Key financial summary

31.5. ZeptoMetrix LLC

31.5.1. Business overview

31.5.2. Product and service offerings

31.6. Quidel Corporation

31.6.1. Business overview

31.6.2. Product and service offerings

31.6.3. Key financial summary

31.7. Maine Molecular Quality Controls Inc.

31.7.1. Business overview

31.7.2. Product and service offerings

31.8. Microbiologics Inc.

31.8.1. Business overview

31.8.2. Product and service offerings

31.9. Bio-Techne Corporation

31.9.1. Business overview

31.9.2. Product and service offerings

31.9.3. Key financial summary

31.10. Qnostics Ltd.

31.10.1. Business overview

31.10.2. Product and service offerings

31.11. Fortress Diagnostics

31.11.1. Business overview

31.11.2. Product and service offerings

31.12. LGC Clinical Diagnostics Inc.

31.12.1. Business overview

31.12.2. Product and service offerings

31.13. Microbix Biosystems Inc.

31.13.1. Business overview

31.13.2. Product and service offerings

31.13.3. Key financial summary

31.14. bioMérieux SA

31.14.1. Business overview

31.14.2. Product and service offerings

31.14.3. Key financial summary

31.15. Anchor Molecular

31.15.1. Business overview

31.15.2. Product and service offerings

Chapter 32. Appendix

32.1. Abbreviations

32.2. Sources and References

32.3. Related Reports

LIST OF FIGURES

FIG 1 MARKET SIZE BREAKDOWN BY SEGMENT

FIG 2 RESEARCH METHODOLOGY

FIG 3 BREAKDOWN OF PRIMARY RESEARCH, BY REGION

FIG 4 BREAKDOWN OF PRIMARY RESEARCH, BY DESIGNATION

FIG 5 BREAKDOWN OF PRIMARY RESEARCH, BY COMPANY TYPE

FIG 6 DATA TRIANGULATION APPROACH

FIG 7 CURRENCY CONVERSION RATES FOR USD (2022)

FIG 8 GLOBAL MOLECULAR QUALITY CONTROLS MARKET SUMMARY

FIG 9 BARGAINING POWER OF BUYERS

FIG 10 BARGAINING POWER OF SUPPLIERS

FIG 11 THREAT OF NEW ENTRANTS

FIG 12 INTENSITY OF RIVALRY

FIG 13 THREAT OF SUBSTITUTES

FIG 14 GLOBAL MOLECULAR QUALITY CONTROLS MARKET SNAPSHOT

FIG 15 GLOBAL MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT TYPE, $M (2017–2030)

FIG 16 GLOBAL MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, $M (2017–2030)

FIG 17 GLOBAL MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, $M (2017–2030)

FIG 18 GLOBAL MOLECULAR QUALITY CONTROLS MARKET, BY END USER, $M (2017–2030)

FIG 19 MAJOR WORLDWIDE MARKETS FOR MOLECULAR QUALITY CONTROLS, $M

FIG 20 NORTH AMERICA MOLECULAR QUALITY CONTROLS MARKET SNAPSHOT

FIG 21 NORTH AMERICA MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT TYPE, $M (2017–2030)

FIG 22 NORTH AMERICA MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, $M (2017–2030)

FIG 23 NORTH AMERICA MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, $M (2017–2030)

FIG 24 NORTH AMERICA MOLECULAR QUALITY CONTROLS MARKET, BY END USER, $M (2017–2030)

FIG 25 NORTH AMERICA MOLECULAR QUALITY CONTROLS MARKET, BY COUNTRY, $M (2017–2030)

FIG 26 EUROPE MOLECULAR QUALITY CONTROLS MARKET SNAPSHOT

FIG 27 EUROPE MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT TYPE, $M (2017–2030)

FIG 28 EUROPE MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, $M (2017–2030)

FIG 29 EUROPE MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, $M (2017–2030)

FIG 30 EUROPE MOLECULAR QUALITY CONTROLS MARKET, BY END USER, $M (2017–2030)

FIG 31 EUROPE MOLECULAR QUALITY CONTROLS MARKET, BY COUNTRY, $M (2017–2030)

FIG 32 APAC MOLECULAR QUALITY CONTROLS MARKET SNAPSHOT

FIG 33 APAC MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT TYPE, $M (2017–2030)

FIG 34 APAC MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, $M (2017–2030)

FIG 35 APAC MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, $M (2017–2030)

FIG 36 APAC MOLECULAR QUALITY CONTROLS MARKET, BY END USER, $M (2017–2030)

FIG 37 APAC MOLECULAR QUALITY CONTROLS MARKET, BY COUNTRY, $M (2017–2030)

FIG 38 LATAM MOLECULAR QUALITY CONTROLS MARKET SNAPSHOT

FIG 39 LATAM MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT TYPE, $M (2017–2030)

FIG 40 LATAM MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, $M (2017–2030)

FIG 41 LATAM MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, $M (2017–2030)

FIG 42 LATAM MOLECULAR QUALITY CONTROLS MARKET, BY END USER, $M (2017–2030)

FIG 43 LATAM MOLECULAR QUALITY CONTROLS MARKET, BY COUNTRY, $M (2017–2030)

FIG 44 MEA MOLECULAR QUALITY CONTROLS MARKET SNAPSHOT

FIG 45 MEA MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT TYPE, $M (2017–2030)

FIG 46 MEA MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, $M (2017–2030)

FIG 47 MEA MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, $M (2017–2030)

FIG 48 MEA MOLECULAR QUALITY CONTROLS MARKET, BY END USER, $M (2017–2030)

FIG 49 MEA MOLECULAR QUALITY CONTROLS MARKET, BY COUNTRY, $M (2017–2030)

FIG 50 U.S. MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT TYPE, $M (2017–2030)

FIG 51 U.S. MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, $M (2017–2030)

FIG 52 U.S. MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, $M (2017–2030)

FIG 53 U.S. MOLECULAR QUALITY CONTROLS MARKET, BY END USER, $M (2017–2030)

FIG 54 CANADA MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT TYPE, $M (2017–2030)

FIG 55 CANADA MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, $M (2017–2030)

FIG 56 CANADA MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, $M (2017–2030)

FIG 57 CANADA MOLECULAR QUALITY CONTROLS MARKET, BY END USER, $M (2017–2030)

FIG 58 GERMANY MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT TYPE, $M (2017–2030)

FIG 59 GERMANY MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, $M (2017–2030)

FIG 60 GERMANY MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, $M (2017–2030)

FIG 61 GERMANY MOLECULAR QUALITY CONTROLS MARKET, BY END USER, $M (2017–2030)

FIG 62 FRANCE MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT TYPE, $M (2017–2030)

FIG 63 FRANCE MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, $M (2017–2030)

FIG 64 FRANCE MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, $M (2017–2030)

FIG 65 FRANCE MOLECULAR QUALITY CONTROLS MARKET, BY END USER, $M (2017–2030)

FIG 66 U.K. MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT TYPE, $M (2017–2030)

FIG 67 U.K. MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, $M (2017–2030)

FIG 68 U.K. MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, $M (2017–2030)

FIG 69 U.K. MOLECULAR QUALITY CONTROLS MARKET, BY END USER, $M (2017–2030)

FIG 70 ITALY MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT TYPE, $M (2017–2030)

FIG 71 ITALY MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, $M (2017–2030)

FIG 72 ITALY MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, $M (2017–2030)

FIG 73 ITALY MOLECULAR QUALITY CONTROLS MARKET, BY END USER, $M (2017–2030)

FIG 74 SPAIN MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT TYPE, $M (2017–2030)

FIG 75 SPAIN MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, $M (2017–2030)

FIG 76 SPAIN MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, $M (2017–2030)

FIG 77 SPAIN MOLECULAR QUALITY CONTROLS MARKET, BY END USER, $M (2017–2030)

FIG 78 JAPAN MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT TYPE, $M (2017–2030)

FIG 79 JAPAN MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, $M (2017–2030)

FIG 80 JAPAN MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, $M (2017–2030)

FIG 81 JAPAN MOLECULAR QUALITY CONTROLS MARKET, BY END USER, $M (2017–2030)

FIG 82 CHINA MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT TYPE, $M (2017–2030)

FIG 83 CHINA MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, $M (2017–2030)

FIG 84 CHINA MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, $M (2017–2030)

FIG 85 CHINA MOLECULAR QUALITY CONTROLS MARKET, BY END USER, $M (2017–2030)

FIG 86 INDIA MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT TYPE, $M (2017–2030)

FIG 87 INDIA MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, $M (2017–2030)

FIG 88 INDIA MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, $M (2017–2030)

FIG 89 INDIA MOLECULAR QUALITY CONTROLS MARKET, BY END USER, $M (2017–2030)

FIG 90 AUSTRALIA MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT TYPE, $M (2017–2030)

FIG 91 AUSTRALIA MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, $M (2017–2030)

FIG 92 AUSTRALIA MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, $M (2017–2030)

FIG 93 AUSTRALIA MOLECULAR QUALITY CONTROLS MARKET, BY END USER, $M (2017–2030)

FIG 94 SOUTH KOREA MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT TYPE, $M (2017–2030)

FIG 95 SOUTH KOREA MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, $M (2017–2030)

FIG 96 SOUTH KOREA MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, $M (2017–2030)

FIG 97 SOUTH KOREA MOLECULAR QUALITY CONTROLS MARKET, BY END USER, $M (2017–2030)

FIG 98 BRAZIL MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT TYPE, $M (2017–2030)

FIG 99 BRAZIL MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, $M (2017–2030)

FIG 100 BRAZIL MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, $M (2017–2030)

FIG 101 BRAZIL MOLECULAR QUALITY CONTROLS MARKET, BY END USER, $M (2017–2030)

FIG 102 MEXICO MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT TYPE, $M (2017–2030)

FIG 103 MEXICO MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, $M (2017–2030)

FIG 104 MEXICO MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, $M (2017–2030)

FIG 105 MEXICO MOLECULAR QUALITY CONTROLS MARKET, BY END USER, $M (2017–2030)

FIG 106 SAUDI ARABIA MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT TYPE, $M (2017–2030)

FIG 107 SAUDI ARABIA MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, $M (2017–2030)

FIG 108 SAUDI ARABIA MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, $M (2017–2030)

FIG 109 SAUDI ARABIA MOLECULAR QUALITY CONTROLS MARKET, BY END USER, $M (2017–2030)

FIG 110 SOUTH AFRICA MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT TYPE, $M (2017–2030)

FIG 111 SOUTH AFRICA MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, $M (2017–2030)

FIG 112 SOUTH AFRICA MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, $M (2017–2030)

FIG 113 SOUTH AFRICA MOLECULAR QUALITY CONTROLS MARKET, BY END USER, $M (2017–2030)

FIG 114 U.A.E. MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT TYPE, $M (2017–2030)

FIG 115 U.A.E. MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, $M (2017–2030)

FIG 116 U.A.E. MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, $M (2017–2030)

FIG 117 U.A.E. MOLECULAR QUALITY CONTROLS MARKET, BY END USER, $M (2017–2030)

FIG 118 THERMO FISHER SCIENTIFIC INC. – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2022)

FIG 119 BIO-RAD LABORATORIES INC. – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2022)

FIG 120 F. HOFFMANN-LA ROCHE LTD. – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2022)

FIG 121 QUIDEL CORPORATION – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2022)

FIG 122 BIO-TECHNE CORPORATION – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2022)

FIG 123 MICROBIX BIOSYSTEMS INC. – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2022)

FIG 124 BIOMÉRIEUX SA – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2022)

※参考情報 分子品質管理（Molecular Quality Controls）は、主にバイオテクノロジーや医療分野において、分子レベルでの品質を保証するための手法やシステムを指します。分子の品質評価は、特に医薬品、診断薬、細胞治療製品などの開発や製造において重要なプロセスとなっています。 分子品質管理には、いくつかの種類があります。第一に、遺伝子やタンパク質などの生体分子の分析において、正確な測定と標準化が求められます。これにより、生成される製品の一貫性や安全性を確保することができます。第二に、プロセスの各段階で使用するコントロールサンプルやリファレンススタンダードの設置が重要です。これらのサンプルは、製造プロセス中や製品の最終検査において、求められる品質基準と照らし合わせるために利用されます。 分子品質管理の用途は多岐にわたります。医薬品の製造過程では、原料の受け入れから製品の出荷まで、すべての段階で品質を確認するためのシステムがあります。特にバイオ医薬品や細胞製品の開発では、成分の特性を厳密に評価する必要があります。さらに、診断薬開発においては、分子の特異性や感度を測定し、患者に対して高い信頼性を持つ診断結果を提供するための試験が必要です。また、生物学的製剤におけるアッセイ技術は、製品のロット間の一貫性を保証するためにも活用されます。 関連技術としては、リアルタイムPCR（ポリメラーゼ鎖反応）や次世代シーケンシング（NGS）、質量分析法などが挙げられます。リアルタイムPCRは、特定のDNAやRNA配列の定量解析を行うために非常に有用で、品品質の確認や感染症の診断に広く利用されています。次世代シーケンシングは、全ゲノムや遺伝子発現の解析において高い精度を提供し、製品の特性評価にも利用されます。質量分析法は、分子の質量や構造を分析するための強力な手法であり、特に複雑なサンプル中の成分の同定や定量において優れた結果を示します。 さらに、分子品質管理には、自動化技術やデータ解析ツールが組み合わさることで、効率的かつ迅速な品質評価が可能になります。例えば、ロボティクスを用いた試料処理や、ビッグデータ解析を活用したトレンド解析などが挙げられます。これにより、製造プロセスの最適化や製品の開発サイクルの短縮が実現します。 分子品質管理は、規制当局（FDA、EMAなど）からの厳格なガイドラインに基づいて実施されることが求められます。これらのガイドラインは、医療分野では患者の安全を守るために非常に重要であり、企業にとっても法的責任を全うするために欠かせない要素です。企業は、品質保証プロセスを厳格に遵守することで、製品の市場投入が可能となります。 さらに、分子品質管理は、研究所や製薬会社だけでなく、大学や公的な研究機関でも重要視されており、これらの機関による基礎研究が新たな品質管理手法の開発に寄与しています。新しい技術の進展に伴って、従来の品質管理手法が進化し続けることが期待されています。 このように、分子品質管理は分子レベルでの厳密な品質評価を通じて、医療やバイオテクノロジーの発展に寄与しています。それによって、より安全で効果的な製品の提供が可能となり、人々の健康と福祉に貢献することができます。分子品質管理は今後も、技術の進歩とともにその重要性を増していくでしょう。